期刊文献+

血液净化并发肝素诱导的血小板减少症临床观察 被引量:7

The Clinical Observation of Heparin-induced Thrombocytopenia of Patients Receiving Blood Purification
下载PDF
导出
摘要 目的观察血液净化中肝素诱导的血小板减少症(HIT)发生及治疗情况,以为其临床治疗提供指导。方法选择行血液灌流(HP)患者341例,连续性静脉-静脉血液滤过(CVVH)患者32例,复合人工肾(CV-VH+HP)患者5例,均给予普通肝素抗凝,观察HIT发生率、发生时间,检测治疗前后血小板的数量、凝血功能,观察出血情况、恢复时间和治疗效果。结果 HP患者中7例在治疗4~36 h后发生HIT(发生率2.05%),血小板最低22×109/L,停用肝素48~96 h血小板恢复正常。CVVH患者中2例发生HIT(发生率6.25%),其中1例在治疗第24 h发生HIT,血小板最低为15×109/L,停用肝素48 h血小板恢复正常;1例在治疗第28 h出现出血症状,血小板进行性下降,最低8×109/L,立即停用肝素,输入新鲜冰冻血浆、浓缩血小板后出血停止,72 h后血小板升至正常。CVVH+HP患者未发生HIT。结论血液净化应用肝素抗凝时应密切观察病情变化,动态监测血小板,对HIT患者立即停用肝素、及时处理。对肝素"过敏"的高危患者应采用无肝素血液净化。 Objective To observe incidence rate,occulwenee time,recovery time and effects of treatment of heparin in- duced thrombocytopenia (HIT) during blood purification. Methods Select 341 cases of patients with hemoperfusion(HP) hospitalized in the First Affiliated Hospital of University of South China,32 cases of patients with composite artificial kidney ( CVVH + HP) during Jan. 2009 to Jan. 2012,and give them with continuous veno-venous hemofihration(CVVH) and 5 cases of patients with heparin for anticoagulant. Then test the number of platelet before and after the treatment ,the coagulation func- tion, and observe bleeding and effects of treatment. Results There was 7 cases during the 4th - 36th hour of HP( HIT inci- dence rate of 2.05% ), the lowest platelet was 22 ×10^9/L, resumed 48h - 96h hours after stopping heparin. Two cases of thrombocytopenia occurred in patients with CVVH( HIT incidence rate of 6.25%). One appeared HIT at the 24th hour,plate- let turned to the lowest of 15 ×10^9/L,and recovered to normal 48 hours later after stopping heparin. The other case bled at the 28th hour, platelet continued reducing to the lowest of 8×10^9/L, heparin was immediately stopped, fresh frozen plasma and condensed platelets was infused, then bleeding ceased and platelets increased to normal 72 hours later. There was no case of thrombocytopenia occurred in patients with CVHH + HP. Conclusions It is essential to observe the changes of disease condition closely, and test platelet dynamically. For patients with HIT, the using of heparin must be stopped and prompt treatment must be taken iunnediately and patients who are sensitive to heparin should receive blood purification without heparin.
出处 《中南医学科学杂志》 CAS 2013年第1期54-57,共4页 Medical Science Journal of Central South China
关键词 肝素 血液灌流 连续性血液净化 血小板减少症 heparin hemoperfusion continuous blood purification thrombocytopenia
  • 相关文献

参考文献14

  • 1Menajovsky LB. Heparin-induced thrombocytopenia:clinical manifestations and management strategies[J].American Journal of Medicine,2005,(08):21-30.
  • 2叶朝阳;赵久石;陆石.血液透析管路通路技术及临床应用[M]上海:复旦大学出版社,2010212.
  • 3Kannan,Meganathana,Ahmad. Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians:relevance to inflammatory markers[J].Blood Coagulation& Fibrinolysis,2008,(06):471-475.
  • 4Warkentin TE,Kelton JG. Temporal aspects of heparin-induced thrombocytopenia[J].New England Journal of Medicine,2001,(17):1286-1292.
  • 5吴鹰,徐玉艳,周卫红.不同血液净化方式对血β_2-微球蛋白清除的影响[J].南华大学学报(医学版),2008,36(2):198-200. 被引量:4
  • 6毛晓玲,郁知非,韦宏成,郑绮宜,陈湛华.血液透析时肝素相关性血小板减少症[J].中华血液学杂志,1999,20(3):161-161. 被引量:6
  • 7黄馥菡,施向东.100例尿毒症血液透析患者肝素诱导的血小板减少症发病率及临床特点[J].浙江实用医学,2011,16(4):259-261. 被引量:8
  • 8Hassan Y,Awaisu A,Aziz NA. Heparin-induced thrombocytopenia and recent advances in its therapy[J].Clinical Pharmacology and Therapeutics,2007,(06):535-544.
  • 9Tsirigotis P,Mantzios G,Makris F. Bilateral renal artery thrombosis due to heparin-induced thrombocytopenia-thrombosis syndrome.Successful treatment with longterm application of lepirudin[J].Ulster Medical Journal,2006,(01):88-90.
  • 10Posadas MA,Hahn D,Schleuter W. Thrombocytopenia associated with dialysis treatments[J].Hemodial Int,2011,(03):416-423.

二级参考文献45

  • 1Warkentin TE,Greinacher A.Heparin-induced thrombocytopenia:recognition,treatment and prevention:the Seventh ACCP conference on antithrombotic and thrombolytic therapy[J].Chest,2004,126:311-337.
  • 2Gustavo BF,Oliveria,Eric M,et al.Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy[J].Arch Intern Meal,2008,168(1):94-102.
  • 3Warkentin T.Heparin-induced thrombocytopenia:pathogenesis and management[J].Br J Haematol,2003,121:535-555.
  • 4Craig S,Kitchens.Thrombocytopenia and thrombosis in disseminated intravoscular coagulation (DIC)[J].American Society of Hematolagy,2009,240-246.
  • 5Wendy Lim.Antiphospholipid antibody syndrome[J].American Society of Hematology,2009,233-239.
  • 6Kannan,Meganathana,Ahmad,et al.Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian Indians:relevance to inflammatory markers[J].Blood coagulation &fihrinolysis,2008,19(6):471-475.
  • 7Warkentin TE,Kelton JG.Temporal aspects of heparin-induced thrombocytopenia[J].N Engl J Med,2001,344:1286-1292.
  • 8Thomas L,Ortel.Heparin-induced thrombocytopenia:when a low platelet count is a mandate for anticoagulation[J].Hematology,2009,225-232.
  • 9Greinacher A, Amiral J, Dumme I V, et al. Laboratory diagnosis of heparin- associated thrombocytopenia and comparision of platelet aggtrgation test, heparin - induced piatelet aggregation test, heparin - induced platelet activation tese, and platelet factor/heparin enzymelinked immtmosorbent assay. Transfusion, 1994,34:381.
  • 10叶朝阳,赵久石,陆石.血液透析管路通路技术及临床应用.上海:复旦大学出版社,2010:212.

共引文献34

同被引文献77

  • 1张小兰.生理盐水与肝素钠液用于静脉留置针封管的临床效果比较[J].中国民康医学,2009,21(19):2451-2452. 被引量:8
  • 2胡大一,孙艺红.低分子肝素与血栓栓塞性疾病[J].中华心血管病杂志,2005,33(2):198-200. 被引量:37
  • 3张晶,段钟平,何金秋,张伦理,陈士彬,邹春毅,辛绍杰,武文芳,马斌荣,陈煜,孔明,刘梅,韩大康.人工肝治疗对重型肝病患者生存期的影响[J].中华肝脏病杂志,2006,14(9):647-651. 被引量:59
  • 4程洪波,李国良,熊丽红,周桂秀,罗敏智,魏宇靖,王晓莉.影响血小板输注疗效的多因素分析[J].江西医学检验,2007,25(2):119-121. 被引量:9
  • 5陈立宇,代华,王丽春,冯萍.重型肝炎治疗方案的理性选择[J].医学与哲学(B),2007,28(4):42-44. 被引量:2
  • 6叶朝阳,赵久石,陆石.血液透析管路通路技术及临床应用[M].上海:复旦大学出版社,2010:212.
  • 7Hochart H, Jenkins P V, Preston R J, et al. Concentration-depentent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood[J]. Thromb Haemost, 2008, 99(3): 570-575.
  • 8van de Wetering J, Westendorp R G, van de Hoeven J G, et al.Heparin use in continuous renal replacement procedures: the steuggle between filter coagulation and patient hemorrhage[J]. J Am Soc Nephrol, 1996, 7(1): 145-150.
  • 9Oudenmans-Van Straaten H M, Wester J P, de Pont A C, et al. Anti- coagulation strategies in continuous renal replacememt therapy: can the choice be evidence based[J].Intensive Care Med, 2006, 32 (2): 188-202.
  • 10Cart JA, Silverman N. The heparin-protamine interaction. A review[J]. J Cardiovase Surg(Torino), 1999, 40(5): 659-666.

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部